Switch View
© BusinessWire
16.09.2025
ISIN: US98888T1079
ZimVie, Inc.
ZIMV
LISTED
NASDAQ
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ZimVie Inc. (NasdaqGS: ZIMV) to an affiliate of ARCHIMED. Under the terms of the proposed transaction, shareholders of ZimVie will receive $19.00 in cash for each share of ZimVie that they ow...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep, kondigt een dubbele strategische AI-initiatieven aan om klinische proeven te transformeren
News Preview
• Lancering van digitale tweelingen en virtuele patiënten om klinische studies te versnellen en te beveiligen
• Integratie van AI-modules in Exagis, de eigen eCRF-oplossing van Axiodis
Leuven, BELGIË, 16 september 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt aan dat zijn dochtervennootschap Axiodis CRO, gespec...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
News Preview
• Launch of digital twins and virtual patients to accelerate and enhance clinical trials
• Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution
Leuven, BELGIUM, September 16, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces that its subsidiary, Axiodis CRO, specialized in clinical data manageme...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques
News Preview
Lancement de jumeaux numériques et de patients virtuels pour accélérer et fiabiliser les essais cliniques.
Intégration de briques d'IA dans Exagis, solution eCRF propriétaire d'Axiodis.
Leuven, BELGIQUE, 16 septembre 2025, 18h00 - Oxurion NV (Euronext Bruxelles : OXUR), annonce que sa filiale Axiodis CR...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
16.09.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
Key Figures
15.09.2025
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.09.2025
16.09.2025 / 17:47 CET/CEST
in CHF
Performance in %
15.09.2025
MTD
FYTD
CYTD
NAV
245.43
2.0
3.5
......
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces plans to build $5 billion manufacturing facility in Virginia
News Preview
New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other advanced therapies
Company will create 2,450 high-wage manufacturing and construction jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
INDIANAPOLIS, Sept. 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
News Preview
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease.Accu-Chek SmartGuide is now available in 13 countries, with plans to accelerate access to over 30 countries across Europe, Latin America and Asia-Pacific by yea...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
News Preview
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease.Accu-Chek SmartGuide is now available in 13 countries, with plans to accelerate access to over 30 countries across Europe, Latin America and Asia-Pacific by yea...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data Randomization to be Completed in Phase II Part in Q4 2025
News Preview
2025 Half-Year Results and Business Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
2025 Half-year financial information
News Preview
2025 Half-year financial information...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Transgene’s Half-Year Financial Report as of June 30, 2025
News Preview
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
News Preview
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP
SALT LAKE CITY, Sept. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Alcon (SIX/NYSE: ALC). S...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025
News Preview
Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue
SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced its participation in two major global health gat...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations base...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lost Money on Lantheus Holdings, Inc.(LNTH)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus Holdings, Inc." or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to r...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ANRO
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to rec...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit.
CLASS DEFI...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit.
CLASS DEFINITION: The la...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) to its request for a Pre-Investigational New...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
News Preview
Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the publication of a study, "Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level," in the American Diabetes Association’s Diabetes Care. The study, a sub-analysis from the 2IQP randomized,...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC LEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 15 September 2025 was 349.21p (cum income). For and on behalf of the B...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced a comprehensive shareholder update, underscoring momentum across its lead clinical programs and corporate strategy. With HT-001 advancing globally, HT-KIT achieving key validation milestones, the expansion o...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
News Preview
Scelfo to strengthen and scale Lucid's market access infrastructure ahead of key upcoming reimbursement milestones—including Medicare coverage for EsoGuard—and to accelerate commercial coverage expansion
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage cancer prevention...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Advances AI Leadership with Next-Generation Denial Prevention and Reimbursement Recovery Innovations
News Preview
Tackling $20 billion lost in denial recovery efforts and $17 billion in uncompensated care, helping providers unlock stronger financial performance and resilience
LEHI, Utah and LOUISVILLE, Ky., Sept. 16, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today will unveil breakthrough innovations at it...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
News Preview
COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by chronic and sustained inflammation;
COYA 303 demonstrated significant attenuation of neuroinflammation in cortex and hippocampus brain regions and...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborativ...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8740602052
Takeda Pharmaceutical Company
TAK
LISTED
NYSE
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
News Preview
Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to CONSTELLATION® Vision System and CENTURION® Vision System with ACTIVE...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /CNW/ -- Pira...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota
News Preview
– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota –...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Announces Chief Financial Officer Transition
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer (CFO), has resigned from her role, effective September 29, 2025, to pursue another opportunity. Following Ms. Pease’s departure, Michael G. Knell, Corporate Senior Vice President and Chief...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents Provides DrugSorb-ATR Regulatory Update
News Preview
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb™-ATR....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CA23344H1091
DRI Healthcare Trust
DHT.U
LISTED
TSX
DRI Healthcare to Present at Upcoming Investor Conferences
News Preview
TORONTO, Sept. 16, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October:...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US75955J4022
Relmada Therapeutics Inc
RLMD
LISTED
NASDAQ
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement
News Preview
CORAL GABLES, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, today announced that on September 15, 2025 it received written notice from the Nasdaq Stock...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
News Preview
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer, will provide an overview and update on the company during a fireside chat session at the Bernstein 2nd Annual Healthcare Forum in New York.
The session will take place on Tuesday, S...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet Announces CFO Transition
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron presents H1 2025 results and provides business update
News Preview
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the half-year ended June 30, 2025, and provided a business update f...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum on Tuesday, September 23, 2025.
The company will take part in a fireside chat beginning at 9:40 a.m. ET.
Investors and the general public are invited to listen to the sess...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare
News Preview
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker’s Hospital Review’s 2025 list of Rising Stars: 100 Healthcare Leaders Under 40.
"A new generation of bold, innovative healthcare leaders is making healthcare more accessible, affordab...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US6283411097
Oncotelic Therapeutics, Inc.
OTLC
LISTED
OTC
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
News Preview
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and cont...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
News Preview
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside in Proctorville, Ohio. It is the Company’s sixth dispensary in Ohio and 71st nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916774840/en/...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
News Preview
Strategic capital deployment advances Company’s blockchain treasury model and biopharma development initiatives...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05280R1005
Autolus Therapeutics plc
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology (ACR) Convergence 2025
News Preview
Autolus announces the publication of an abstract submitted to the American College of Rheumatology (ACR) Convergence 2025, to be held October 24-29, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
News Preview
In Australia and Europe In Australia and Europe...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US00688A2050
Adial Pharmaceuticals Inc
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
News Preview
FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
News Preview
NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CRB-701 for the treatment of recurrent or metastatic head and nec...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
News Preview
- Findings highlight the potential of antibiotic-eluting bioenvelopes to transform cardiac implantable electronic device (CIED) pocket management -...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
News Preview
A Media Snippet accompanying this announcement is available by clicking on this link....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
